OA04567A - Nouveaux dérivés de l'imidazo (2,1-b) thiazole et leur préparation. - Google Patents

Nouveaux dérivés de l'imidazo (2,1-b) thiazole et leur préparation.

Info

Publication number
OA04567A
OA04567A OA55057A OA55057A OA04567A OA 04567 A OA04567 A OA 04567A OA 55057 A OA55057 A OA 55057A OA 55057 A OA55057 A OA 55057A OA 04567 A OA04567 A OA 04567A
Authority
OA
OAPI
Prior art keywords
imidazo
thiazole
preparation
new derivatives
derivatives
Prior art date
Application number
OA55057A
Other languages
English (en)
French (fr)
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7242580A external-priority patent/FR2207708A1/fr
Priority claimed from FR7335158A external-priority patent/FR2245348A1/fr
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of OA04567A publication Critical patent/OA04567A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/34Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA55057A 1972-11-30 1973-11-08 Nouveaux dérivés de l'imidazo (2,1-b) thiazole et leur préparation. OA04567A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7242580A FR2207708A1 (en) 1972-11-30 1972-11-30 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity
FR7335158A FR2245348A1 (en) 1973-10-02 1973-10-02 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity

Publications (1)

Publication Number Publication Date
OA04567A true OA04567A (fr) 1980-05-31

Family

ID=26217429

Family Applications (1)

Application Number Title Priority Date Filing Date
OA55057A OA04567A (fr) 1972-11-30 1973-11-08 Nouveaux dérivés de l'imidazo (2,1-b) thiazole et leur préparation.

Country Status (20)

Country Link
US (1) US4005212A (ja)
JP (1) JPS5314077B2 (ja)
AR (1) AR203186A1 (ja)
AT (1) AT329554B (ja)
BE (1) BE808008A (ja)
CA (1) CA1002955A (ja)
CH (1) CH579577A5 (ja)
DD (1) DD107697A5 (ja)
DE (1) DE2359864A1 (ja)
DK (1) DK136823B (ja)
ES (1) ES421011A1 (ja)
GB (1) GB1404708A (ja)
HU (1) HU167368B (ja)
IE (1) IE38552B1 (ja)
IL (1) IL43723A (ja)
LU (1) LU68887A1 (ja)
NL (1) NL7316016A (ja)
OA (1) OA04567A (ja)
SE (1) SE399894B (ja)
SU (1) SU518133A3 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179460A (en) * 1977-07-06 1979-12-18 Dso "Pharmachim" Derivatives of R,S-[X2-(2-hydroxyethylamino)-1-phenyl]-ethylamine, and process
US4370482A (en) 1978-02-15 1983-01-25 American Cyanamid Co. Synthesis of tetramisole, levamisole and their derivatives
US4620009A (en) * 1980-03-17 1986-10-28 Cyanamid Agricultural De Puerto Rico, Inc. Synthesis of intermediates for tetramisole, levamisole and their derivatives
ZA827736B (en) * 1981-11-25 1983-08-31 Pfizer Bicyclic imidazole and imidazolines as ectoparasiticides and anthelmintics
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU409983B2 (en) * 1965-07-19 1970-12-31 Imperial Chemical Industries Of Australia New Zealand Limited Process for the manufacture of thia zolidines and thiazolidines produced thereby

Also Published As

Publication number Publication date
LU68887A1 (ja) 1974-07-05
DD107697A5 (ja) 1974-08-12
NL7316016A (ja) 1974-06-04
SU518133A3 (ru) 1976-06-15
JPS5314077B2 (ja) 1978-05-15
US4005212A (en) 1977-01-25
GB1404708A (en) 1975-09-03
BE808008A (fr) 1974-05-29
DK136823B (da) 1977-11-28
IL43723A (en) 1976-07-30
AU6300973A (en) 1975-05-29
IE38552L (en) 1974-05-30
AT329554B (de) 1976-05-25
AR203186A1 (es) 1975-08-22
DK136823C (ja) 1978-05-08
SE399894B (sv) 1978-03-06
IE38552B1 (en) 1978-04-12
CH579577A5 (ja) 1976-09-15
DE2359864A1 (de) 1974-06-06
ATA1005173A (de) 1975-08-15
ES421011A1 (es) 1976-06-16
IL43723A0 (en) 1974-03-14
CA1002955A (fr) 1977-01-04
HU167368B (ja) 1975-09-27
JPS4993390A (ja) 1974-09-05

Similar Documents

Publication Publication Date Title
OA04285A (fr) Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
OA03692A (fr) Nouveaux dérivés du benzo-cyclohepta-thiopène et leur préparation.
FR2343748A1 (fr) Derives de 2,3-dihydro imidazo (2,1-b) thiazole, leur procede de preparation et leur application en therapeutique
OA03907A (fr) Procédé de préparation de nouveaux dérivés de l'isoindoline.
OA03699A (fr) Nouveaux dérivés de l'indole et leur préparation.
OA04019A (fr) Nouveaux dérivés de l'oxadiazolone, leur préparation et les compositions qui les contiennent.
FI54925C (fi) Foerfarande foer framstaellning av hostlindrande och blodtryckssaenkande 2-amino-4,5,7,8-tetrahydro-6h-tiazolo- och oxazolo (5,4-d)azepiner
OA04294A (fr) Nouveaux dérivés de l'isoindoline et leur procédé de préparation.
OA04129A (fr) Dérivés de la quinazoline et leur préparation.
OA04567A (fr) Nouveaux dérivés de l'imidazo (2,1-b) thiazole et leur préparation.
OA03835A (fr) Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
OA04286A (fr) Nouveaux dérivés de l'isoindoline et leur préparation.
OA05033A (fr) Nouveaux dérivés de la céphalosporine et leur préparation.
OA03536A (fr) Nouveaux dérivés de la 4-amino-quinazoline et leur préparation.
FR95283E (fr) Nouveaux dérivés de l'isoindolino sulfonyluree et leur procédé de préparation.
OA03392A (fr) Nouveaux dérivés du thiazole et leur préparation.
BE824037A (fr) Nouveaux derives de l'imidazo (2,1a) isoquinoleine
FI55664C (fi) Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo-(1,2-a)-s-triaziner
OA03831A (fr) Nouveaux dérivés de l'O-phénylenediamine, leur préparation et les compositions qui les contiennent.
OA04084A (fr) Nouveaux dérivés de l'isoindoline et leur préparation.
OA03651A (fr) Nouveaux dérivés de la dibenzazépine et leur préparation.
OA04416A (fr) Procédé de préparation de nouveaux dérivés d'acétamide.
OA04935A (fr) Dérivés céphem et leur préparation.
OA04407A (fr) Procédé de préparation d'arylènes substitués anthelmintiques.
OA04561A (fr) Nouveaux dérivés de cyclohexanediol et leur procédé de préparation.